Leveraging expertise developed from his extensive work with HIV, Jackson Laboratory (JAX) Professor Read moreled an effort to develop an assay that determines how well anti-SARS-CoV-2 antibodies are able to neutralize binding with ACE-2, the human receptor for the virus. Using a non-infectious pseudo-virus with the SARS-CoV-2 spike protein on the external membrane, the assay does not require a BSL-3-level biosecurity facility, yet detects the presence of neutralizing antibodies with extremely high sensitivity and specificity. In a pre-print posted on medRxiv, Unutmaz shows that the assay is able to detect neutralizing antibody in patient plasma even at high dilutions, up to a million-fold.
Maine’s startup ‘mojo’ highlighted in national ranking
As a place to start a business, Maine’s “mojo” is going strong, as shown in a new national ranking released Tuesday by WalletHub,...
Maine CDC Director Nirav Shah to join U.S. CDC leadership
Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, has been appointed principal deputy director at the...
$5.6M in state funding to support Maine startups, entrepreneurs
Sixteen Maine organizations helping startups and entrepreneurs will share $5.6 million in state funding from the Pandemic Recovery for an Innovative Maine...